The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

NCT00830570 · clinicaltrials.gov ↗

COMPLETED

Status

1635

Enrollment

INDUSTRY

Sponsor class

Conditions

Embolism and Thrombosis
Embolism
Vascular Diseases
Warfarin
Venous Thromboembolism
Thrombosis
Thromboembolism

Interventions

OTHER: CYP 2C9 and VKORC1 Testing for Warfarin

Sponsor

Medco Health Solutions, Inc.

Collaborators

[object Object]
[object Object]